Literature DB >> 8126150

Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues.

M Mercado1, N DáVila, J F McLeod, G Baumann.   

Abstract

The extent of expression of the GH receptor (GHR) in human tissues is largely unknown. In some cell lines and placenta, the GHR gene generates two different mRNAs by alternative splicing of exon 3, one coding for a full-length receptor (GHR + 3) and the other for a receptor isoform that lacks exon 3 (GHR-3), with deletion of amino acid residues 7-28. To determine the distribution of the GHR and the relative abundance of its two isoforms in man, we studied a variety of tissues obtained at autopsy by reverse transcription and polymerase chain reaction (PCR) amplification, using isoform-specific primers. The nature of the PCR products was verified by restriction analysis and DNA sequencing. The relative proportions of the two GHR isoforms were determined by competitive PCR using a 32P-labeled anti-sense primer and a mixture of both isoform-specific sense primers in equimolar amounts. Electrophoretic bands corresponding to the amplification products were excised and counted, or quantitated by laser densitometry. Restriction analysis and sequencing of the amplified products were consistent with their predicted sequence. Both GHR transcripts were found in all 19 tissues tested, but their relative proportions varied depending on the tissue and, to a lesser extent, between subjects. They ranged from a preponderance of GHR-3 (kidney, bladder, adrenal, and brain stem) to a predominance of GHR + 3 (skeletal muscle and liver). We conclude that the GHR gene is widely expressed in human tissues. Both GHR + 3 and GHR-3 transcripts are present, but their relative proportions depend on the tissue and, possibly, the metabolic status. The physiological significance of the existence of two human GHR forms remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126150     DOI: 10.1210/jcem.78.3.8126150

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism.

Authors:  M L Stallings-Mann; R L Ludwiczak; K W Klinger; F Rottman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 2.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

3.  Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.

Authors:  Feida Li; Yong Li; Huan Liu; Xingju Zhang; Chuxin Liu; Kai Tian; Lars Bolund; Hongwei Dou; Wenxian Yang; Huanming Yang; Nicklas Heine Staunstrup; Yutao Du
Journal:  Transgenic Res       Date:  2015-10-28       Impact factor: 2.788

4.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

Authors:  Y Zhou; B C Xu; H G Maheshwari; L He; M Reed; M Lozykowski; S Okada; L Cataldo; K Coschigamo; T E Wagner; G Baumann; J J Kopchick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Localization of growth hormone receptor messenger RNA in human tissues.

Authors:  H C Mertani; M C Delehaye-Zervas; J F Martini; M C Postel-Vinay; G Morel
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

6.  Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein.

Authors:  F Dastot; M L Sobrier; P Duquesnoy; B Duriez; M Goossens; S Amselem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Immunodetection of Insulin-Like Growth Factor I (IGF-l) in Normal and Pathological Adrenocortical Tissue.

Authors:  Samir Faical; Rui M. B. Maciel; Vania Nose-Alberti; Marivania C. Santos; Claudio E. Kater
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

8.  Association between the Growth Hormone Receptor Exon 3 Polymorphism and Metabolic Factors in Korean Patients with Acromegaly.

Authors:  Hye Yoon Park; In Ryang Hwang; Jung Bum Seo; Su Won Kim; Hyun Ae Seo; In Kyu Lee; Jung Guk Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2015-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.